N/A
N=3,367
HPV Self-Sampling in Somali Women (Isbaar Project)
Cervical Cancer · Papillomavirus Infection · Uterine Diseases · Uterine Cervical Disease
Bottom Line
View on ClinicalTrials.gov: NCT05453006 ↗Enrolled (actual)
3,367
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Difference-in-difference Comparison — 1.8 Hazard ratio
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- COPAN 552c.80 FLOQSwab (Device)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- Female
- Sponsor
- University of Minnesota
- Primary completion
- May 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference-in-difference Comparison |
1.8 | — |
| PRIMARY Pre-implementation Period Cervical Cancer Screening Completion |
170; 482 | — |
| PRIMARY Post-implementation Period Cervical Cancer Screening Completion. |
303; 436 | — |
Summary
This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.
Eligibility Criteria
Inclusion Criteria
- Identify as a Somali woman
- between ages of 30-65
- eligible for cervical cancer screening
Exclusion Criteria
- Ineligible for cervical cancer screening, including having a history of cervical cancer or a hysterectomy without intact cervix
Data sourced from ClinicalTrials.gov (NCT05453006). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.